HEPION PHARMACEUTICALS, INC. Repayments of Long-Term Debt
HEPION PHARMACEUTICALS, INC. (HEPA) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2023-04-10
- HEPION PHARMACEUTICALS, INC. repayments of long-term debt for the quarter ending 2022-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. repayments of long-term debt for the quarter ending 2022-09-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. repayments of long-term debt for the quarter ending 2021-09-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. repayments of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HEPION PHARMACEUTICALS, INC. repayments of long-term debt for fiscal 2021 was $176.59K.
- HEPION PHARMACEUTICALS, INC. repayments of long-term debt for fiscal 2020 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | $0.00 derived: sum of 2 quarters · filed 2023-04-10 | $0.00 10-K · filed 2023-04-10 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | $0.00 derived: sum of 2 quarters · filed 2023-04-10 | $176.59K 10-K · filed 2023-04-10 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $176.59K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $176.59K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $0.00 derived: sum of 2 quarters · filed 2022-04-08 | $0.00 10-K · filed 2022-04-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |